Abstract:Background: Glucose variability is predictive of cardiovascular events and all-cause mortality. However, the association between peripheral artery disease and glucose variability has not been thoroughly investigated. Therefore, the standard deviation of annual haemoglobin A1c was assessed in patients with type 2 diabetes for evaluating the different risks of peripheral artery disease. Methods: A total of 4144 patients underwent an evaluation for the ankle-brachial index and the percentage of mean arterial pres… Show more
“…The baPWV was calculated as (distance from the suprasternal notch to the brachiumdistance from the suprasternal notch to the ankle)/(the time interval between waves detected at the brachium and ankle), where the distances from the suprasternal notch to the brachium and ankle were estimated based on the patient's body height [18]. The reproducibility of the ABI and %MAP has been demonstrated in our previous study [19], and the 95% con dence interval (CI) between repeated measurements of baPWV was 4.95 ± 46.46 cm/sec based on Bland-Altman plots. The lower ABI value and the higher %MAP and baPWV values between lower limbs in an individual were used for the analyses.…”
Section: Assessmentsmentioning
confidence: 91%
“…The lower ABI value and the higher %MAP and baPWV values between lower limbs in an individual were used for the analyses. ABI ≤ 0.90 and %MAP > 45% were de ned as abnormal [13,19].…”
Background: Peripheral artery disease (PAD) in the lower extremities is a common complication of type 2 diabetes and has been shown to be associated with mortality. The ankle-brachial index (ABI) is a simple noninvasive method to screen PAD, but this method has limited sensitivity. We hypothesized that using the percentage of mean arterial pressure (%MAP) in combination with the ABI would improve the prediction of mortality.Methods: We retrospectively collected data from patients with type 2 diabetes who had undergone ABI and %MAP measurements at our hospital. We separated the cohort into four groups according to their ABI and %MAP values, and we examined whether these indices were associated with mortality.Results: A total of 5569 patients (mean age, 65 ± 11 years) were enrolled. During the follow-up period (median, 22.9 months), 266 (4.8%) of the enrolled patients died. The combination of ABI and %MAP was significantly more effective than ABI alone for predicting mortality (C index of 0.62, 95% confidence interval [CI] of 0.57 to 0.65 vs. C index of 0.57, 95% CI of 0.53 to 0.62; P = 0.038). In multivariate analysis (with a reference group defined by ABI >0.90 and %MAP ≤45%), the highest risk of mortality was seen in patients with ABI ≤0.90 and %MAP >45% (hazard ratio = 2.045 [95% CI: 1.420, 2.945], P < 0.001).Conclusions: The use of %MAP alongside ABI appears to significantly improve the prediction of all-cause mortality in patients with type 2 diabetes.
“…The baPWV was calculated as (distance from the suprasternal notch to the brachiumdistance from the suprasternal notch to the ankle)/(the time interval between waves detected at the brachium and ankle), where the distances from the suprasternal notch to the brachium and ankle were estimated based on the patient's body height [18]. The reproducibility of the ABI and %MAP has been demonstrated in our previous study [19], and the 95% con dence interval (CI) between repeated measurements of baPWV was 4.95 ± 46.46 cm/sec based on Bland-Altman plots. The lower ABI value and the higher %MAP and baPWV values between lower limbs in an individual were used for the analyses.…”
Section: Assessmentsmentioning
confidence: 91%
“…The lower ABI value and the higher %MAP and baPWV values between lower limbs in an individual were used for the analyses. ABI ≤ 0.90 and %MAP > 45% were de ned as abnormal [13,19].…”
Background: Peripheral artery disease (PAD) in the lower extremities is a common complication of type 2 diabetes and has been shown to be associated with mortality. The ankle-brachial index (ABI) is a simple noninvasive method to screen PAD, but this method has limited sensitivity. We hypothesized that using the percentage of mean arterial pressure (%MAP) in combination with the ABI would improve the prediction of mortality.Methods: We retrospectively collected data from patients with type 2 diabetes who had undergone ABI and %MAP measurements at our hospital. We separated the cohort into four groups according to their ABI and %MAP values, and we examined whether these indices were associated with mortality.Results: A total of 5569 patients (mean age, 65 ± 11 years) were enrolled. During the follow-up period (median, 22.9 months), 266 (4.8%) of the enrolled patients died. The combination of ABI and %MAP was significantly more effective than ABI alone for predicting mortality (C index of 0.62, 95% confidence interval [CI] of 0.57 to 0.65 vs. C index of 0.57, 95% CI of 0.53 to 0.62; P = 0.038). In multivariate analysis (with a reference group defined by ABI >0.90 and %MAP ≤45%), the highest risk of mortality was seen in patients with ABI ≤0.90 and %MAP >45% (hazard ratio = 2.045 [95% CI: 1.420, 2.945], P < 0.001).Conclusions: The use of %MAP alongside ABI appears to significantly improve the prediction of all-cause mortality in patients with type 2 diabetes.
“…In the present study, the risk factors signi cantly associated with %MAP in both the different ABI groups, included age, CVD history, BMI, HbA1c, eGFR, UACR, baPWV, use of antiplatelet agents, type of oral antihyperglycemic drug, and type of hypertensive drug (Table 1). However, we did not include all cardiovascular risk factors in the present study; for example, a higher HbA1c variability has been previously reported to be associated with a higher %MAP [15]. Furthermore, this study has several limitations.…”
mentioning
confidence: 94%
“…The %MAP value was automatically determined based on the ankle pulse volume waveform during ABI measurement. The reproducibilities of the ABI and %MAP have been demonstrated using Bland-Altman plots in our previous study [15]. The lower ABI value, and the higher %MAP and baPWV values between lower limbs in an individual were used for the analyses.…”
mentioning
confidence: 99%
“…The lower ABI value, and the higher %MAP and baPWV values between lower limbs in an individual were used for the analyses. ABI ≤ 0.90 and %MAP > 45% were de ned as abnormal [12,15].…”
Background: Peripheral artery disease (PAD) in lower extremities is a common complication in type 2 diabetes and has shown to be associated with mortality. The ankle-brachial index (ABI) is a simple noninvasive method to screen PAD, but has limited sensitivity. We hypothesized that using the percentage of mean arterial pressure (%MAP) and the ABI in combination would improve prediction of mortality.Methods: We retrospectively collected the data of patients with type 2 diabetes who had undergone measurement of ABI and %MAP at our hospital. We separated the cohort into four groups according to the ABI and %MAP values, and examined these indices were associated with mortality.Results: A total of 5101 patients (mean age, 65 ± 11 years) were enrolled. During the follow-up period (median, 22.9 months), 266 (4.8%) of enrolled patients died. The combination of ABI and %MAP was significantly better at predicting mortality than ABI alone. (C index: 0.62 [95% CI: 0.57, 0.65] vs. 0.57 [95% CI: 0.53, 0.62], P = 0.038). In multivariate analysis (with ABI >0.90 and %MAP ≤45% as the reference group), the highest risk of mortality was seen in patients with ABI ≤0.90 and %MAP >45% (hazard ratio = 1.983 [95% CI: 1.380, 2.848], P < 0.001).Conclusions: Adding %MAP to ABI appears to significantly improve the predictive ability for all-cause mortality in patients with type 2 diabetes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.